Peptides for Weight Loss: Beyond Semaglutide
Semaglutide changed everything. When Wegovy was approved for weight loss in 2021, it proved that peptide-based medications could achieve what decades of dieting advice couldn't — consistent, significant weight loss for millions of people. But the peptide weight loss landscape extends far beyond semaglutide.
Whether you can't access semaglutide, want to explore complementary options, or are simply curious about what else is out there, this guide covers the full spectrum of peptides with weight loss potential.
The GLP-1 Agonists: The Gold Standard
Before exploring alternatives, it's important to understand why GLP-1 agonists work so well.
GLP-1 (glucagon-like peptide-1) is a natural hormone released by your gut after eating. It signals to the brain that you're full, slows stomach emptying, and improves insulin sensitivity. GLP-1 agonists like semaglutide simply supercharge this natural system.
Tirzepatide: The Dual Agonist
Tirzepatide (Mounjaro/Zepbound) is arguably the biggest competitor to semaglutide, and clinical data suggests it may be even more effective. As a dual GIP/GLP-1 receptor agonist, it activates two appetite and metabolic pathways simultaneously.
The numbers: SURMOUNT-1 trial showed an average 22.5% body weight loss at the highest dose — significantly more than semaglutide's ~17%. For many patients, tirzepatide may be the more effective choice.
Emerging GLP-1 Compounds
Retatrutide (Eli Lilly): A triple agonist targeting GIP, GLP-1, and glucagon receptors. Phase 2 results showed up to 24% body weight loss at 48 weeks. Phase 3 trials are ongoing.
Survodutide (Boehringer Ingelheim): A dual glucagon/GLP-1 agonist. Phase 2 data showed up to 18.7% weight loss, with particularly strong effects on liver fat.
Orforglipron (Eli Lilly): An oral, non-peptide GLP-1 agonist. Phase 2 showed up to 14.7% weight loss with a daily pill — no injections needed.
AOD-9604: The Fat-Specific Fragment
AOD-9604 (Advanced Obesity Drug) is a modified fragment of human growth hormone — specifically, amino acids 177-191 of the GH molecule, with an added tyrosine. It was designed to isolate the fat-burning properties of growth hormone without its other effects.
How it works:
The appeal: AOD-9604 targets fat specifically without the metabolic complications of full growth hormone therapy. It doesn't affect appetite — it works purely on fat metabolism.
Research status: AOD-9604 went through Phase 2 clinical trials for obesity but did not advance to Phase 3 due to modest results compared to now-available GLP-1 agonists. It remains available as a research peptide and through some compounding pharmacies. The TGA (Australia's FDA equivalent) has approved it as a food supplement.
Typical dosing: 300 mcg daily via subcutaneous injection, administered on an empty stomach in the morning.
Tesamorelin: FDA-Approved Body Composition Changer
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that is FDA-approved for reducing visceral adipose tissue (VAT) in HIV patients with lipodystrophy. It's increasingly used off-label for body composition optimization.
How it works: Tesamorelin stimulates the pituitary to release natural growth hormone, which in turn promotes fat metabolism. Unlike synthetic HGH, it works through your body's own regulatory mechanisms.
Weight loss specifics:
Important distinction: Tesamorelin's strength is where it removes fat, not how much. Visceral fat is the metabolically active, dangerous fat linked to heart disease, diabetes, and inflammation. Reducing visceral fat improves metabolic health markers even if the scale doesn't move dramatically.
Typical dosing: 2 mg subcutaneously once daily.
CJC-1295/Ipamorelin: Indirect Fat Loss Through GH
The CJC-1295/ipamorelin stack isn't a direct weight loss protocol, but it supports fat loss through growth hormone optimization.
Fat loss mechanisms:
Realistic expectations: Don't expect dramatic scale changes. CJC-1295/ipamorelin typically produces a slow, steady recomposition — losing fat while maintaining or gaining lean mass. Many users report looking leaner without significant changes in body weight.
Best for: People who are already training and eating well, looking for an additional edge in body composition.
5-Amino-1MQ: The Metabolism Booster
5-Amino-1MQ is a small molecule (not technically a peptide, but often grouped with them) that inhibits the enzyme NNMT (nicotinamide N-methyltransferase). NNMT is overexpressed in fat tissue and contributes to metabolic dysfunction.
How it works:
Research status: Promising preclinical data, but limited human studies. Available as a research compound and through some clinics.
Typical dosing: 50-150 mg taken orally, 1-2 times daily.
MOTS-c: The Mitochondrial Peptide
MOTS-c is a naturally occurring mitochondrial-derived peptide that acts as an exercise mimetic — it activates some of the same metabolic pathways as physical exercise.
How it works:
Weight loss potential: MOTS-c may help improve metabolic function and insulin sensitivity, making it easier for the body to burn fat effectively. Animal studies show prevention of diet-induced obesity and improved glucose homeostasis.
Typical dosing: 5-10 mg subcutaneously, 2-3 times per week.
Building a Weight Loss Peptide Strategy
Not everyone needs or wants a GLP-1 agonist. Here's how different peptides fit different situations:
Maximum Weight Loss
Moderate Fat Loss + Body Composition
Visceral Fat + Metabolic Health
Adjuncts to Existing Diet/Exercise
The Non-Negotiable Foundations
Peptides are tools, not magic. The following foundations determine 80%+ of your results:
Caloric awareness: You don't need to count every calorie, but understanding energy balance matters. Even GLP-1 agonists work primarily by reducing food intake.
Protein priority: Adequate protein (1.6-2.2 g/kg body weight) preserves muscle during weight loss — this is critical for long-term metabolic health.
Resistance training: The single best intervention for maintaining muscle mass during caloric restriction. Muscle is metabolically active tissue; losing it tanks your metabolism.
Sleep: Poor sleep disrupts leptin and ghrelin (hunger hormones), increases cortisol, and promotes visceral fat storage. 7-9 hours is non-negotiable.
Stress management: Chronic stress elevates cortisol, which directly promotes abdominal fat storage and increases appetite.
The Muscle Preservation Problem
One of the biggest concerns with dramatic weight loss (especially from GLP-1 agonists) is muscle loss. Studies show 25-40% of weight lost on these medications can be lean mass.
Strategies to minimize this:
Conclusion
The peptide landscape for weight loss extends well beyond semaglutide. From tirzepatide's superior dual-agonist approach to AOD-9604's fat-specific targeting to tesamorelin's visceral fat reduction, there are multiple peptide-based strategies for different goals and circumstances.
The best approach combines the right peptide tool with solid nutritional habits, consistent exercise, quality sleep, and medical guidance. No peptide replaces these fundamentals — but the right one can meaningfully amplify your results.
Medical Disclaimer
This article is for educational and informational purposes only and does not constitute medical advice. Some peptides discussed are prescription medications requiring medical supervision, while others are research compounds not approved by the FDA. Always consult a qualified healthcare professional before starting any weight loss protocol. Do not use this information to self-diagnose or self-treat any health condition.